Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.55p
   
  • Change Today:
    -0.30p
  • 52 Week High: 14.13
  • 52 Week Low: 3.50
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 888,756
  • Market Cap: £4.70m
  • RiskGrade: 435

Latest ShareCast News

ValiRx inks deal with Dundee Drug Discovery Unit

By Josh White

Date: Monday 12 Feb 2024

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

ValiRx enters option deal with Ambrose Healthcare

By Josh White

Date: Tuesday 05 Dec 2023

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

ValiRx enters partnership with StingRay Bio

By Josh White

Date: Friday 10 Nov 2023

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.55p
Change Today -0.30p
% Change -7.79 %
52 Week High 14.13
52 Week Low 3.50
Volume 888,756
Shares Issued 132.35m
Market Cap £4.70m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.54% below the market average23.54% below the market average23.54% below the market average23.54% below the market average23.54% below the market average
7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average
Price Trend
89.26% below the market average89.26% below the market average89.26% below the market average89.26% below the market average89.26% below the market average
64.91% below the sector average64.91% below the sector average64.91% below the sector average64.91% below the sector average64.91% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:19 20,000 @ 3.59p
16:15 13,380 @ 3.55p
16:05 36,000 @ 3.55p
16:02 60,340 @ 3.51p
16:01 250,000 @ 3.59p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page